Florbetapir-PET imaging and postmortem beta-amyloid pathology

JAMA. 2011 May 11;305(18):1857; author reply 1857-8. doi: 10.1001/jama.2011.579.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Alzheimer Disease / diagnostic imaging*
  • Amyloid beta-Peptides / analysis
  • Aniline Compounds*
  • Autopsy
  • Brain Chemistry
  • Drug Approval
  • Endpoint Determination
  • Ethylene Glycols*
  • Humans
  • Observer Variation*
  • Positron-Emission Tomography
  • Radiopharmaceuticals*
  • United States
  • United States Food and Drug Administration

Substances

  • Amyloid beta-Peptides
  • Aniline Compounds
  • Ethylene Glycols
  • Radiopharmaceuticals
  • florbetapir